SlideShare a Scribd company logo
IDSA GUIDELINES 
Practice Guidelines for the 
Diagnosis and Management of 
Skin and Soft Tissue Infections: 
2014 Update by the Infectious 
Diseases Society of America 
Clinical Infectious Diseases 2014; 59(2):147–59
What Is the Appropriate 
Evaluation and Treatment for 
Purulent SSTIs (Cutaneous 
Abscesses, Furuncles, 
Carbuncles, and Inflamed 
Epidermoid Cysts)?
Management of Skin and Soft Tissue Infections: IDSA Guideline 2014
Gram stain and culture of pus from 
carbuncles and abscesses are 
recommended, but treatment without 
these studies is reasonable in typical 
cases (strong, moderate).
Gram stain and culture of pus from inflamed 
epidermoid cysts are not recommended 
(strong, moderate).
Incision and drainage is the 
recommended treatment for inflamed 
epidermoid cysts, carbuncles, abscesses, 
and large furuncles, mild (strong, high).
The decision to administer antibiotics directed 
against S. aureus as an adjunct to incision 
and drainage should be made based upon 
presence or absence of systemic inflammatory 
response syndrome (SIRS), such as 
temperature >38℃ or <36℃, tachypnea >24 
bpm, tachycardia >90 bpm, or WBC >12000 or 
< 400 cells/μL (moderate) (strong, low). 
An antibiotic active against MRSA is 
recommended for patients with carbuncles or 
abscesses who have failed initial antibiotic 
treatment or have markedly impaired host 
defenses or in patients with SIRS and 
hypotension (severe) (strong, low).
Management of Skin and Soft Tissue Infections: IDSA Guideline 2014
Management of Skin and Soft Tissue Infections: IDSA Guideline 2014
Management of Skin and Soft Tissue Infections: IDSA Guideline 2014
What Is Appropriate for the 
Evaluation and Treatment of 
Erysipelas and Cellulitis?
Cultures of blood or cutaneous aspirates, 
biopsies, or swabs are not routinely 
recommended (strong, moderate).
Cultures of blood are recommended 
(strong, moderate), and cultures and 
microscopic examination of cutaneous 
aspirates, biopsies, or swabs should be 
considered in patients with malignancy 
on chemotherapy, neutropenia, severe 
cell-mediated immunodeficiency, 
immersion injuries, and animal bites 
(weak, moderate).
Typical cases of cellulitis without systemic signs of infection 
should receive an antimicrobial agent that is active against 
streptococci (mild) (strong, moderate). 
For cellulitis with systemic signs of infection (moderate 
nonpurulent), systemic antibiotics are indicated. Many 
clinicians could include coverage against MSSA (weak, low). 
For patients whose cellulitis is associated with penetrating 
trauma, evidence of MRSA infection elsewhere, nasal 
colonization with MRSA, injection drug use, or SIRS 
(severe nonpurulent), vancomycin or another antimicrobial 
effective against both MRSA and streptococci is 
recommended (strong, moderate). 
In severely compromised patients (severe nonpurulent), 
broad-spectrum antimicrobial coverage may be considered 
(weak, moderate). Vancomycin plus either piperacillin-tazobactam 
or imipenem/meropenem is recommended as 
a reasonable empiric regimen for severe 
infections (strong, moderate).
The recommended duration of antimicrobial 
therapy is 5 days, but treatment should 
be extended if the infection has not 
improved within this time period (strong, 
high).
In lower-extremity cellulitis, clinicians should 
carefully examine the interdigital toe 
spaces because treating fissuring, scaling, 
or maceration may eradicate colonization 
with pathogens and reduce the incidence 
of recurrent infection (strong, moderate).
Outpatient therapy is recommended for 
patients who do not have SIRS, altered 
mental status, or hemodynamic instability 
(mild nonpurulent) (strong, moderate). 
Hospitalization is recommended if there is 
concern for a deeper or necrotizing infection, 
for patients with poor adherence to therapy, 
for infection in a severely 
immunocompromised patient, or if outpatient 
treatment is failing (moderate or severe 
nonpurulent) (strong, moderate).
Should Anti-inflammatory Agents 
Be Used to Complement 
Antibiotic Treatment of 
Cellulitis?
Systemic corticosteroids (eg, prednisone 
40 mg daily for 7 days) could be 
considered in nondiabetic adult patients 
with cellulitis (weak, moderate).
What Is the Preferred Evaluation 
and Management of Patients 
With Recurrent Cellulitis?
Identify and treat predisposing conditions 
such as edema, obesity, eczema, venous 
insufficiency, and toe web abnormalities 
(strong, moderate). These practices 
should be performed as part of routine 
patient care and certainly during the acute 
stage of cellulitis (strong, moderate).
Administration of prophylactic antibiotics, 
such as oral penicillin or erythromycin bid 
for 4–52 weeks, or intramuscular 
benzathine penicillin every 2–4 weeks, 
should be considered in patients who have 
3–4 episodes of cellulitis per year despite 
attempts to treat or control predisposing 
factors (weak, moderate). This program 
should be continued so long as the 
predisposing factors persist (strong, 
moderate).
What Is the Preferred 
Management of Surgical Site 
Infections?
Management of Skin and Soft Tissue Infections: IDSA Guideline 2014
Suture removal plus I&D should be 
performed for surgical site infections 
(strong, low).
Adjunctive systemic antimicrobial therapy is 
not routinely indicated, but in conjunction 
with I&D may be beneficial for surgical 
site infections associated with a 
significant systemic response, such as 
erythema and induration extending >5 cm 
from the wound edge, temperature>38.5℃, 
heart rate >110 bpm, or WBC >12 000/μL 
(weak, low).
A brief course of systemic antimicrobial 
therapy is indicated in patients with 
surgical site infections following clean 
operations on the trunk, head and neck, 
or extremities that also have systemic 
signs of infection (strong, low).
A first-generation cephalosporin or an anti-staphylococcal 
penicillin for MSSA, or 
vancomycin, linezolid, daptomycin, 
telavancin, or ceftaroline where risk factors 
for MRSA are high (nasal colonization, 
prior MRSA infection, recent 
hospitalization, recent antibiotics), is 
recommended (strong, low).
Agents active against gram-negative 
bacteria and anaerobes, such as a 
cephalosporin or fluoroquinolone in 
combination with metronidazole, are 
recommended for infections following 
operations on the axilla, GI tract, 
perineum, or female genital tract (strong, 
low).
Management of Skin and Soft Tissue Infections: IDSA Guideline 2014
What Is the Preferred Evaluation 
and Treatment of Necrotizing 
Fasciitis, Including Fournier 
Gangrene?
Prompt surgical consultation is 
recommended for patients with aggressive 
infections associated with signs of 
systemic toxicity or suspicion of 
necrotizing fasciitis or gas gangrene 
(severe nonpurulent) (strong, low).
Empiric antibiotic treatment should be broad 
(eg, vancomycin or linezolid plus 
piperacillin-tazobactam or a carbapenem; 
or plus ceftriaxone and metronidazole), as 
the etiology can be poly-microbial (mixed 
aerobic–anaerobic microbes) or mono-microbial 
(group A streptococci, 
community-acquired MRSA) (strong, low).
Penicillin plus clindamycin is recommended 
for treatment of documented group A 
streptococcal necrotizing fasciitis (strong, 
low).
Management of Skin and Soft Tissue Infections: IDSA Guideline 2014
What Is the Appropriate 
Approach to the Management 
of Pyomyositis?
MRI is the recommended imaging modality 
for establishing the diagnosis of 
pyomyositis. CT and ultrasound studies 
are also useful (strong, moderate).
Cultures of blood and abscess material 
should be obtained (strong, moderate).
Vancomycin is recommended for initial 
empirical therapy. An agent active against 
enteric gram-negative bacilli should be 
added for infection in immuno-compromised 
patients or following open 
trauma to the muscles (strong, moderate).
Cefazolin or anti-staphylococcal penicillin 
(eg, nafcillin or oxacillin) is recommended 
for treatment of pyomyositis caused by 
MSSA (strong, moderate).
Early drainage of purulent material should 
be performed (strong, high).
Repeat imaging studies should be 
performed in the patient with persistent 
bacteremia to identify undrained foci of 
infection (strong, low).
Antibiotics should be administered 
intravenously initially, but once the patient 
is clinically improved, oral antibiotics are 
appropriate for patients in whom 
bacteremia cleared promptly and there is 
no evidence of endocarditis or metastatic 
abscess. Two to 3 weeks of therapy is 
recommended (strong, low).
What Is the Appropriate 
Approach to the Evaluation and 
Treatment of Clostridial Gas 
Gangrene or Myonecrosis?
Urgent surgical exploration of the 
suspected gas gangrene site and surgical 
debridement of involved tissue should be 
performed (severe nonpurulent) (strong, 
moderate).
In the absence of a definitive etiologic 
diagnosis, broadspectrum treatment with 
vancomycin plus either 
piperacillin/tazobactam, 
ampicillin/sulbactam, or a carbapenem 
antimicrobial is recommended (strong, 
low). Definitive antimicrobial therapy with 
penicillin and clindamycin is recommended 
for treatment of clostridial myonecrosis 
(strong, low).
Hyperbaric oxygen (HBO) therapy is 
not recommended because it has not 
been proven as a benefit to the patient 
and may delay resuscitation and surgical 
debridement (strong, low).
What Is the Role of Preemptive 
Antimicrobial Therapy to 
Prevent Infection for Dog or Cat 
Bites?
Preemptive early antimicrobial therapy for 
3–5 days is recommended for patients 
who 
a) are immunocompromised 
b) are asplenic 
c) have advanced liver disease 
d) have preexisting or resultant edema of the 
affected area 
e) have moderate to severe injuries, especially 
to the hand or face 
f) have injuries that may have penetrated the 
periosteum or joint capsule (strong, low).
Postexposure prophylaxis for rabies may be 
indicated;consultation with local health 
officials is recommended to determine if 
vaccination should be initiated (strong, 
low).
What Is the Treatment for 
Infected Animal Bite–Related 
Wounds?
An antimicrobial agent or agents active 
against both aerobic and anaerobic 
bacteria such as amoxicillin-clavulanate 
should be used (strong, moderate).
Management of Skin and Soft Tissue Infections: IDSA Guideline 2014
Should Tetanus Toxoid Be 
Administered for Animal Bite 
Wounds?
Tetanus toxoid should be administered to 
patients without toxoid vaccination within 
10 years. Tetanus, diptheria, and tetanus 
(Tdap) is preferred over Tetanus and 
diptheria (Td) if the former has not been 
previously given (strong, low).
In Which Patients Is Primary 
Wound Closure Appropriate for 
Animal Bite Wounds?
Primary wound closure is not recommended 
for wounds, with the exception of those to 
the face, which should be managed with 
copious irrigation, cautious debridement, 
and preemptive antibiotics (strong, low). 
Other wounds may be approximated 
(weak, low).
Management of Skin and Soft Tissue Infections: IDSA Guideline 2014

More Related Content

PDF
Time Management & Productivity - Best Practices
PPTX
Time Management
PPTX
An Introduction to Immunohistochemistry
PPTX
PPTX
Disorders of Platelets
PPTX
Congenital syphilis
PPT
Management of shock
PPTX
Hyperlipidemia and lipid lowering drugs
Time Management & Productivity - Best Practices
Time Management
An Introduction to Immunohistochemistry
Disorders of Platelets
Congenital syphilis
Management of shock
Hyperlipidemia and lipid lowering drugs

What's hot (20)

PPTX
Antifungals in icu
PPTX
Post Cardiac Arrest Syndrome
PPTX
Guidelines of febrile neutropenia
PPTX
VAP/HAP management guidelines by IDSA/ATS (2016) -: Dr.Tinku Joseph
PPTX
Antibiotics in icu
PPTX
Sepsis hemodynamic update part two
PPTX
Sepsis guideline 2021.pptx
PPTX
Management of sepsis and septic shock
PPTX
Sepsis and septic shock guidelines 2021. part 1
PPTX
Skin and Soft Tissue Infections
PPTX
COMMUNITY AQUIRED PNEUMONIA
PPTX
Septic shock management
PPTX
ROSE CONCEPT.pptx
PPTX
Dvt prophylaxis in icu
PPT
PPSX
Fungal diseases intensivist should know
PPTX
USES AND ADVANTAGES OF OCTREOTIDE.pptx
PPTX
Invasive fungal infection in icu
PPTX
Managing MDR/XDR Gram Negative infections in ICU
PPTX
Sepsis and septic shock
Antifungals in icu
Post Cardiac Arrest Syndrome
Guidelines of febrile neutropenia
VAP/HAP management guidelines by IDSA/ATS (2016) -: Dr.Tinku Joseph
Antibiotics in icu
Sepsis hemodynamic update part two
Sepsis guideline 2021.pptx
Management of sepsis and septic shock
Sepsis and septic shock guidelines 2021. part 1
Skin and Soft Tissue Infections
COMMUNITY AQUIRED PNEUMONIA
Septic shock management
ROSE CONCEPT.pptx
Dvt prophylaxis in icu
Fungal diseases intensivist should know
USES AND ADVANTAGES OF OCTREOTIDE.pptx
Invasive fungal infection in icu
Managing MDR/XDR Gram Negative infections in ICU
Sepsis and septic shock
Ad

Similar to Management of Skin and Soft Tissue Infections: IDSA Guideline 2014 (20)

PPTX
Sepsis managment in hospitalized patients
PDF
Skin soft tissue care guide
PDF
CHRONIC Staphylococcus aureus infection - 2014 jan31 - VRSA
PPTX
Febrile neutropaenia
PPT
Antibiotic in ED
PDF
Brain Abscess - Algorithmic approach
PPTX
Infections in geriatrics
PPTX
Approach to the therapy of cap , vap and hap
PPTX
Antibiotic Strategy in Lower Respiratory Tract Infections (part 2)
PPTX
Community acquired pneumonia 2015 part 2
PPTX
Community acquired pneumonia 2015 part 2
PPTX
Febrile neutropenia ankur
PPTX
strategies LTX.pptx
PDF
Relapsing coagulase negative staphylococcus peritonitis
PPTX
Febrile neutropenia - Infections in cancer patients
PPTX
MRSA AN UPDATE
PPTX
Sepsis guidelines 2013
PPTX
Management of infections in immunocompromised patients
PPTX
Chapter 30 febrile neutropenia
Sepsis managment in hospitalized patients
Skin soft tissue care guide
CHRONIC Staphylococcus aureus infection - 2014 jan31 - VRSA
Febrile neutropaenia
Antibiotic in ED
Brain Abscess - Algorithmic approach
Infections in geriatrics
Approach to the therapy of cap , vap and hap
Antibiotic Strategy in Lower Respiratory Tract Infections (part 2)
Community acquired pneumonia 2015 part 2
Community acquired pneumonia 2015 part 2
Febrile neutropenia ankur
strategies LTX.pptx
Relapsing coagulase negative staphylococcus peritonitis
Febrile neutropenia - Infections in cancer patients
MRSA AN UPDATE
Sepsis guidelines 2013
Management of infections in immunocompromised patients
Chapter 30 febrile neutropenia
Ad

More from Sun Yai-Cheng (20)

PPTX
COVID-19 (Coronavirus disease 2019), part 2
PPTX
COVID-19 (Coronavirus disease 2019) update
PPTX
Initial Care of the Severely Injured Patient
PPTX
Management of Heart Failure in ED
PPTX
2018 Stroke Guidelines
PPTX
DAWN and DEFUSE 3 trial
PDF
ATLS 10th Edition Compendium of Change
PPTX
The European Guideline on Management of Major Bleeding and Coagulopathy Follo...
PPTX
Surviving Sepsis Guidelines 2016
PPTX
VBG or ABG analysis in Emergency Care?
PPTX
Top 10 Myths Regarding the Diagnosis and Treatment of UTI
PPTX
ACEP Policy for Fever Infants and Children Younger than 2 Years of Age in ED
PPTX
Focused Cardiac Ultrasound
PPTX
ACLS 2015
PDF
Post–Cardiac Arrest Care
PDF
2015 AHA CPR & ECC 更新重點提要
PPTX
2015 AHA/ASA Focused Update Guidelines for Acute Ischemic Stroke Regarding En...
PPTX
Best Mobile Medical Apps in ED
PPTX
Use of tPA for the Management of Acute Ischemic Stroke in the ED: ACEP Policy
PPTX
Evaluation and Management of Acute Aortic Dissection: ACEP Policy
COVID-19 (Coronavirus disease 2019), part 2
COVID-19 (Coronavirus disease 2019) update
Initial Care of the Severely Injured Patient
Management of Heart Failure in ED
2018 Stroke Guidelines
DAWN and DEFUSE 3 trial
ATLS 10th Edition Compendium of Change
The European Guideline on Management of Major Bleeding and Coagulopathy Follo...
Surviving Sepsis Guidelines 2016
VBG or ABG analysis in Emergency Care?
Top 10 Myths Regarding the Diagnosis and Treatment of UTI
ACEP Policy for Fever Infants and Children Younger than 2 Years of Age in ED
Focused Cardiac Ultrasound
ACLS 2015
Post–Cardiac Arrest Care
2015 AHA CPR & ECC 更新重點提要
2015 AHA/ASA Focused Update Guidelines for Acute Ischemic Stroke Regarding En...
Best Mobile Medical Apps in ED
Use of tPA for the Management of Acute Ischemic Stroke in the ED: ACEP Policy
Evaluation and Management of Acute Aortic Dissection: ACEP Policy

Recently uploaded (20)

PDF
The_EHRA_Book_of_Interventional Electrophysiology.pdf
PPTX
Wheat allergies and Disease in gastroenterology
PPTX
Approach to chest pain, SOB, palpitation and prolonged fever
PPTX
IMAGING EQUIPMENiiiiìiiiiiTpptxeiuueueur
PDF
OSCE Series Set 1 ( Questions & Answers ).pdf
DOCX
PEADIATRICS NOTES.docx lecture notes for medical students
PPTX
y4d nutrition and diet in pregnancy and postpartum
PPT
Rheumatology Member of Royal College of Physicians.ppt
PPTX
Neoplasia III.pptxjhghgjhfj fjfhgfgdfdfsrbvhv
PPTX
Hearthhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh
PPTX
NUCLEAR-MEDICINE-Copy.pptxbabaabahahahaahha
PDF
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
PPT
nephrology MRCP - Member of Royal College of Physicians ppt
PDF
OSCE SERIES - Set 7 ( Questions & Answers ).pdf
PDF
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
PDF
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf
PDF
OSCE SERIES ( Questions & Answers ) - Set 5.pdf
PDF
AGE(Acute Gastroenteritis)pdf. Specific.
PPTX
Radiation Dose Management for Patients in Medical Imaging- Avinesh Shrestha
PPT
Infections Member of Royal College of Physicians.ppt
The_EHRA_Book_of_Interventional Electrophysiology.pdf
Wheat allergies and Disease in gastroenterology
Approach to chest pain, SOB, palpitation and prolonged fever
IMAGING EQUIPMENiiiiìiiiiiTpptxeiuueueur
OSCE Series Set 1 ( Questions & Answers ).pdf
PEADIATRICS NOTES.docx lecture notes for medical students
y4d nutrition and diet in pregnancy and postpartum
Rheumatology Member of Royal College of Physicians.ppt
Neoplasia III.pptxjhghgjhfj fjfhgfgdfdfsrbvhv
Hearthhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh
NUCLEAR-MEDICINE-Copy.pptxbabaabahahahaahha
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
nephrology MRCP - Member of Royal College of Physicians ppt
OSCE SERIES - Set 7 ( Questions & Answers ).pdf
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf
OSCE SERIES ( Questions & Answers ) - Set 5.pdf
AGE(Acute Gastroenteritis)pdf. Specific.
Radiation Dose Management for Patients in Medical Imaging- Avinesh Shrestha
Infections Member of Royal College of Physicians.ppt

Management of Skin and Soft Tissue Infections: IDSA Guideline 2014

  • 1. IDSA GUIDELINES Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America Clinical Infectious Diseases 2014; 59(2):147–59
  • 2. What Is the Appropriate Evaluation and Treatment for Purulent SSTIs (Cutaneous Abscesses, Furuncles, Carbuncles, and Inflamed Epidermoid Cysts)?
  • 4. Gram stain and culture of pus from carbuncles and abscesses are recommended, but treatment without these studies is reasonable in typical cases (strong, moderate).
  • 5. Gram stain and culture of pus from inflamed epidermoid cysts are not recommended (strong, moderate).
  • 6. Incision and drainage is the recommended treatment for inflamed epidermoid cysts, carbuncles, abscesses, and large furuncles, mild (strong, high).
  • 7. The decision to administer antibiotics directed against S. aureus as an adjunct to incision and drainage should be made based upon presence or absence of systemic inflammatory response syndrome (SIRS), such as temperature >38℃ or <36℃, tachypnea >24 bpm, tachycardia >90 bpm, or WBC >12000 or < 400 cells/μL (moderate) (strong, low). An antibiotic active against MRSA is recommended for patients with carbuncles or abscesses who have failed initial antibiotic treatment or have markedly impaired host defenses or in patients with SIRS and hypotension (severe) (strong, low).
  • 11. What Is Appropriate for the Evaluation and Treatment of Erysipelas and Cellulitis?
  • 12. Cultures of blood or cutaneous aspirates, biopsies, or swabs are not routinely recommended (strong, moderate).
  • 13. Cultures of blood are recommended (strong, moderate), and cultures and microscopic examination of cutaneous aspirates, biopsies, or swabs should be considered in patients with malignancy on chemotherapy, neutropenia, severe cell-mediated immunodeficiency, immersion injuries, and animal bites (weak, moderate).
  • 14. Typical cases of cellulitis without systemic signs of infection should receive an antimicrobial agent that is active against streptococci (mild) (strong, moderate). For cellulitis with systemic signs of infection (moderate nonpurulent), systemic antibiotics are indicated. Many clinicians could include coverage against MSSA (weak, low). For patients whose cellulitis is associated with penetrating trauma, evidence of MRSA infection elsewhere, nasal colonization with MRSA, injection drug use, or SIRS (severe nonpurulent), vancomycin or another antimicrobial effective against both MRSA and streptococci is recommended (strong, moderate). In severely compromised patients (severe nonpurulent), broad-spectrum antimicrobial coverage may be considered (weak, moderate). Vancomycin plus either piperacillin-tazobactam or imipenem/meropenem is recommended as a reasonable empiric regimen for severe infections (strong, moderate).
  • 15. The recommended duration of antimicrobial therapy is 5 days, but treatment should be extended if the infection has not improved within this time period (strong, high).
  • 16. In lower-extremity cellulitis, clinicians should carefully examine the interdigital toe spaces because treating fissuring, scaling, or maceration may eradicate colonization with pathogens and reduce the incidence of recurrent infection (strong, moderate).
  • 17. Outpatient therapy is recommended for patients who do not have SIRS, altered mental status, or hemodynamic instability (mild nonpurulent) (strong, moderate). Hospitalization is recommended if there is concern for a deeper or necrotizing infection, for patients with poor adherence to therapy, for infection in a severely immunocompromised patient, or if outpatient treatment is failing (moderate or severe nonpurulent) (strong, moderate).
  • 18. Should Anti-inflammatory Agents Be Used to Complement Antibiotic Treatment of Cellulitis?
  • 19. Systemic corticosteroids (eg, prednisone 40 mg daily for 7 days) could be considered in nondiabetic adult patients with cellulitis (weak, moderate).
  • 20. What Is the Preferred Evaluation and Management of Patients With Recurrent Cellulitis?
  • 21. Identify and treat predisposing conditions such as edema, obesity, eczema, venous insufficiency, and toe web abnormalities (strong, moderate). These practices should be performed as part of routine patient care and certainly during the acute stage of cellulitis (strong, moderate).
  • 22. Administration of prophylactic antibiotics, such as oral penicillin or erythromycin bid for 4–52 weeks, or intramuscular benzathine penicillin every 2–4 weeks, should be considered in patients who have 3–4 episodes of cellulitis per year despite attempts to treat or control predisposing factors (weak, moderate). This program should be continued so long as the predisposing factors persist (strong, moderate).
  • 23. What Is the Preferred Management of Surgical Site Infections?
  • 25. Suture removal plus I&D should be performed for surgical site infections (strong, low).
  • 26. Adjunctive systemic antimicrobial therapy is not routinely indicated, but in conjunction with I&D may be beneficial for surgical site infections associated with a significant systemic response, such as erythema and induration extending >5 cm from the wound edge, temperature>38.5℃, heart rate >110 bpm, or WBC >12 000/μL (weak, low).
  • 27. A brief course of systemic antimicrobial therapy is indicated in patients with surgical site infections following clean operations on the trunk, head and neck, or extremities that also have systemic signs of infection (strong, low).
  • 28. A first-generation cephalosporin or an anti-staphylococcal penicillin for MSSA, or vancomycin, linezolid, daptomycin, telavancin, or ceftaroline where risk factors for MRSA are high (nasal colonization, prior MRSA infection, recent hospitalization, recent antibiotics), is recommended (strong, low).
  • 29. Agents active against gram-negative bacteria and anaerobes, such as a cephalosporin or fluoroquinolone in combination with metronidazole, are recommended for infections following operations on the axilla, GI tract, perineum, or female genital tract (strong, low).
  • 31. What Is the Preferred Evaluation and Treatment of Necrotizing Fasciitis, Including Fournier Gangrene?
  • 32. Prompt surgical consultation is recommended for patients with aggressive infections associated with signs of systemic toxicity or suspicion of necrotizing fasciitis or gas gangrene (severe nonpurulent) (strong, low).
  • 33. Empiric antibiotic treatment should be broad (eg, vancomycin or linezolid plus piperacillin-tazobactam or a carbapenem; or plus ceftriaxone and metronidazole), as the etiology can be poly-microbial (mixed aerobic–anaerobic microbes) or mono-microbial (group A streptococci, community-acquired MRSA) (strong, low).
  • 34. Penicillin plus clindamycin is recommended for treatment of documented group A streptococcal necrotizing fasciitis (strong, low).
  • 36. What Is the Appropriate Approach to the Management of Pyomyositis?
  • 37. MRI is the recommended imaging modality for establishing the diagnosis of pyomyositis. CT and ultrasound studies are also useful (strong, moderate).
  • 38. Cultures of blood and abscess material should be obtained (strong, moderate).
  • 39. Vancomycin is recommended for initial empirical therapy. An agent active against enteric gram-negative bacilli should be added for infection in immuno-compromised patients or following open trauma to the muscles (strong, moderate).
  • 40. Cefazolin or anti-staphylococcal penicillin (eg, nafcillin or oxacillin) is recommended for treatment of pyomyositis caused by MSSA (strong, moderate).
  • 41. Early drainage of purulent material should be performed (strong, high).
  • 42. Repeat imaging studies should be performed in the patient with persistent bacteremia to identify undrained foci of infection (strong, low).
  • 43. Antibiotics should be administered intravenously initially, but once the patient is clinically improved, oral antibiotics are appropriate for patients in whom bacteremia cleared promptly and there is no evidence of endocarditis or metastatic abscess. Two to 3 weeks of therapy is recommended (strong, low).
  • 44. What Is the Appropriate Approach to the Evaluation and Treatment of Clostridial Gas Gangrene or Myonecrosis?
  • 45. Urgent surgical exploration of the suspected gas gangrene site and surgical debridement of involved tissue should be performed (severe nonpurulent) (strong, moderate).
  • 46. In the absence of a definitive etiologic diagnosis, broadspectrum treatment with vancomycin plus either piperacillin/tazobactam, ampicillin/sulbactam, or a carbapenem antimicrobial is recommended (strong, low). Definitive antimicrobial therapy with penicillin and clindamycin is recommended for treatment of clostridial myonecrosis (strong, low).
  • 47. Hyperbaric oxygen (HBO) therapy is not recommended because it has not been proven as a benefit to the patient and may delay resuscitation and surgical debridement (strong, low).
  • 48. What Is the Role of Preemptive Antimicrobial Therapy to Prevent Infection for Dog or Cat Bites?
  • 49. Preemptive early antimicrobial therapy for 3–5 days is recommended for patients who a) are immunocompromised b) are asplenic c) have advanced liver disease d) have preexisting or resultant edema of the affected area e) have moderate to severe injuries, especially to the hand or face f) have injuries that may have penetrated the periosteum or joint capsule (strong, low).
  • 50. Postexposure prophylaxis for rabies may be indicated;consultation with local health officials is recommended to determine if vaccination should be initiated (strong, low).
  • 51. What Is the Treatment for Infected Animal Bite–Related Wounds?
  • 52. An antimicrobial agent or agents active against both aerobic and anaerobic bacteria such as amoxicillin-clavulanate should be used (strong, moderate).
  • 54. Should Tetanus Toxoid Be Administered for Animal Bite Wounds?
  • 55. Tetanus toxoid should be administered to patients without toxoid vaccination within 10 years. Tetanus, diptheria, and tetanus (Tdap) is preferred over Tetanus and diptheria (Td) if the former has not been previously given (strong, low).
  • 56. In Which Patients Is Primary Wound Closure Appropriate for Animal Bite Wounds?
  • 57. Primary wound closure is not recommended for wounds, with the exception of those to the face, which should be managed with copious irrigation, cautious debridement, and preemptive antibiotics (strong, low). Other wounds may be approximated (weak, low).